HISTOGEN INC.

SAN DIEGO, CA How do I update this listing?

Histogen is based out of San Diego. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection.Whalewisdom has at least 51 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-11-18. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

histogen inc.
10655 SORRENTO VALLEY ROAD
SAN DIEGO CA    92121

Business Phone: (858) 526-3100
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-11-18 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 189,208 189,208 0
2013-06-13 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 1,001,551 1,001,551 0
2011-02-17 D BIOTECHNOLOGY Equity 25,275,507 25,275,507 0
2010-10-28 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security 5,000,000 5,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALFRED P. SPADA subscription required
    EXECUTIVE OFFICER
ALFRED P. SPADA, PH.D. subscription required
    EXECUTIVE OFFICER
BRIAN SATZ, ESQ. subscription required
    DIRECTOR
CHARLES J. CASHION subscription required
    EXECUTIVE OFFICER
DANIEL KISNER, M.D. subscription required
    DIRECTOR
DAVID CREAN, PH.D. subscription required
    DIRECTOR
DAVID F. HALE subscription required
    DIRECTOR
GAIL NAUGHTON subscription required
    EXECUTIVE OFFICER
GARY C. BURGESS subscription required
    EXECUTIVE OFFICER
HAROLD VAN WART subscription required
    DIRECTOR
HAROLD VAN WART, M.D. subscription required
    DIRECTOR
HAYDEN YIZHUO ZHANG subscription required
    DIRECTOR
JAMES SCOPA subscription required
    DIRECTOR
JENNIFER GIOTTONINI CAYER subscription required
    EXECUTIVE OFFICER
JONATHAN JACKSON subscription required
    DIRECTOR
LOUIS LACASSE subscription required
    DIRECTOR
MARC PERET subscription required
    DIRECTOR
MARC PERRET subscription required
    DIRECTOR
MARTIN LATTERICH subscription required
    EXECUTIVE OFFICER
MOYA DANIELS subscription required
    EXECUTIVE OFFICER
PAUL KLINGENSTEIN subscription required
    DIRECTOR
RICHARD W. PASCOE subscription required
    EXECUTIVE OFFICER DIRECTOR
SHAHZAD MALIK subscription required
    DIRECTOR
SHAHZAD MALIK, M.D. subscription required
    DIRECTOR
STEPHEN CHANG, PH.D. subscription required
    DIRECTOR
STEVEN J. MENTO subscription required
    EXECUTIVE OFFICER DIRECTOR
STEVEN J. MENTO, PH.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
SUSAN A. KNUDSON subscription required
    EXECUTIVE OFFICER
WILLIAM GERBER subscription required
    DIRECTOR
WILLIAM GERBER, M.D. subscription required
    DIRECTOR

Elevate your investments